164 related articles for article (PubMed ID: 29029099)
1. Biomarkers of Mineral and Bone Metabolism and 20-Year Risk of Hospitalization With Infection: The Atherosclerosis Risk in Communities Study.
Ishigami J; Jaar BG; Rebholz CM; Grams ME; Michos ED; Wolf M; Kovesdy CP; Uchida S; Coresh J; Lutsey PL; Matsushita K
J Clin Endocrinol Metab; 2017 Dec; 102(12):4648-4657. PubMed ID: 29029099
[TBL] [Abstract][Full Text] [Related]
2. Kidney function, bone-mineral metabolism markers, and future risk of peripheral artery disease.
Yang C; Kwak L; Ballew SH; Garimella PS; Jaar BG; Folsom AR; Heiss G; Selvin E; Lutsey PL; Coresh J; Matsushita K
Atherosclerosis; 2017 Dec; 267():167-174. PubMed ID: 28992939
[TBL] [Abstract][Full Text] [Related]
3. Associations of fibroblast growth factor 23, vitamin D and parathyroid hormone with 5-year outcomes in a prospective primary care cohort of people with chronic kidney disease stage 3.
Shardlow A; McIntyre NJ; Fluck RJ; McIntyre CW; Taal MW
BMJ Open; 2017 Aug; 7(8):e016528. PubMed ID: 28838895
[TBL] [Abstract][Full Text] [Related]
4. Impact of Race on the Association of Mineral Metabolism With Heart Failure: the Multi-Ethnic Study of Atherosclerosis.
Robinson-Cohen C; Shlipak M; Sarnak M; Katz R; Peralta C; Young B; Hoofnagle AN; Szklo M; Ix JH; Psaty BM; de Boer IH; Kestenbaum B; Bansal N
J Clin Endocrinol Metab; 2020 Apr; 105(4):e1144-51. PubMed ID: 31760429
[TBL] [Abstract][Full Text] [Related]
5. Serum magnesium, bone-mineral metabolism markers and their interactions with kidney function on subsequent risk of peripheral artery disease: the Atherosclerosis Risk in Communities Study.
Menez S; Ding N; Grams ME; Lutsey PL; Heiss G; Folsom AR; Selvin E; Coresh J; Jaar BG; Matsushita K
Nephrol Dial Transplant; 2020 Nov; 35(11):1878-1885. PubMed ID: 32191294
[TBL] [Abstract][Full Text] [Related]
6. The relationship between urinary kidney injury molecule-1 and blood bone metabolism markers in patients with chronic kidney disease
.
Yin C; Cheng C; Wang J; Zhang L; Purrunsing Y; Yang G; Zeng M; Huang H; Ren W; Ye Y; Ma H; Xing C; Wang N
Clin Nephrol; 2020 Feb; 93(2):65-76. PubMed ID: 31793871
[TBL] [Abstract][Full Text] [Related]
7. Markers of vitamin D metabolism and incidence of clinically diagnosed abdominal aortic aneurysm: The Atherosclerosis Risk in Communities Study.
Lutsey PL; Rooney MR; Folsom AR; Michos ED; Alonso A; Tang W
Vasc Med; 2018 Jun; 23(3):253-260. PubMed ID: 29400142
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast Growth Factor 23 and Risk of CKD Progression in Children.
Portale AA; Wolf MS; Messinger S; Perwad F; Jüppner H; Warady BA; Furth SL; Salusky IB
Clin J Am Soc Nephrol; 2016 Nov; 11(11):1989-1998. PubMed ID: 27561289
[TBL] [Abstract][Full Text] [Related]
9. Combined use of vitamin D status and FGF23 for risk stratification of renal outcome.
Nakano C; Hamano T; Fujii N; Matsui I; Tomida K; Mikami S; Inoue K; Obi Y; Okada N; Tsubakihara Y; Isaka Y; Rakugi H
Clin J Am Soc Nephrol; 2012 May; 7(5):810-9. PubMed ID: 22362065
[TBL] [Abstract][Full Text] [Related]
10. Serum parathyroid hormone and 25-hydroxyvitamin D concentrations and risk of incident heart failure: the Multi-Ethnic Study of Atherosclerosis.
Bansal N; Zelnick L; Robinson-Cohen C; Hoofnagle AN; Ix JH; Lima JA; Shoben AB; Peralta CA; Siscovick DS; Kestenbaum B; de Boer IH
J Am Heart Assoc; 2014 Dec; 3(6):e001278. PubMed ID: 25468653
[TBL] [Abstract][Full Text] [Related]
11. Serum fibroblast growth factor 23 and mineral metabolism in patients with euthyroid Graves' diseases: a case-control study.
Lin CH; Chang CK; Shih CW; Li HY; Chen KY; Yang WS; Tsai KS; Wang CY; Shih SR
Osteoporos Int; 2019 Nov; 30(11):2289-2297. PubMed ID: 31384956
[TBL] [Abstract][Full Text] [Related]
12. Serum FGF23 and risk of cardiovascular events in relation to mineral metabolism and cardiovascular pathology.
Ärnlöv J; Carlsson AC; Sundström J; Ingelsson E; Larsson A; Lind L; Larsson TE
Clin J Am Soc Nephrol; 2013 May; 8(5):781-6. PubMed ID: 23335040
[TBL] [Abstract][Full Text] [Related]
13. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.
Pavik I; Jaeger P; Ebner L; Wagner CA; Petzold K; Spichtig D; Poster D; Wüthrich RP; Russmann S; Serra AL
Nephrol Dial Transplant; 2013 Feb; 28(2):352-9. PubMed ID: 23129826
[TBL] [Abstract][Full Text] [Related]
14. Intact fibroblast growth factor 23 levels predict incident cardiovascular event before but not after the start of dialysis.
Nakano C; Hamano T; Fujii N; Obi Y; Matsui I; Tomida K; Mikami S; Inoue K; Shimomura A; Nagasawa Y; Okada N; Tsubakihara Y; Rakugi H; Isaka Y
Bone; 2012 Jun; 50(6):1266-74. PubMed ID: 22425694
[TBL] [Abstract][Full Text] [Related]
15. Applicability of fibroblast growth factor 23 for evaluation of risk of vertebral fracture and chronic kidney disease-mineral bone disease in elderly chronic kidney disease patients.
Kanda E; Yoshida M; Sasaki S
BMC Nephrol; 2012 Sep; 13():122. PubMed ID: 23013306
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast Growth Factor 23 and the Risk of Infection-Related Hospitalization in Older Adults.
Nowak KL; Bartz TM; Dalrymple L; de Boer IH; Kestenbaum B; Shlipak MG; Garimella PS; Ix JH; Chonchol M
J Am Soc Nephrol; 2017 Apr; 28(4):1239-1246. PubMed ID: 28122946
[TBL] [Abstract][Full Text] [Related]
17. Mineral metabolites and CKD progression in African Americans.
Scialla JJ; Astor BC; Isakova T; Xie H; Appel LJ; Wolf M
J Am Soc Nephrol; 2013 Jan; 24(1):125-35. PubMed ID: 23243213
[TBL] [Abstract][Full Text] [Related]
18. Detecting high-risk chronic kidney disease-mineral bone disorder phenotypes among patients on dialysis: a historical cohort study.
Neri L; Kreuzberg U; Bellocchio F; Brancaccio D; Barbieri C; Canaud B; Stuard S; Ketteler M
Nephrol Dial Transplant; 2019 Apr; 34(4):682-691. PubMed ID: 30165528
[TBL] [Abstract][Full Text] [Related]
19. Race, Mineral Homeostasis and Mortality in Patients with End-Stage Renal Disease on Dialysis.
Scialla JJ; Parekh RS; Eustace JA; Astor BC; Plantinga L; Jaar BG; Shafi T; Coresh J; Powe NR; Melamed ML
Am J Nephrol; 2015; 42(1):25-34. PubMed ID: 26287973
[TBL] [Abstract][Full Text] [Related]
20. Association of kidney function, vitamin D deficiency, and circulating markers of mineral and bone disorders in CKD.
Ureña-Torres P; Metzger M; Haymann JP; Karras A; Boffa JJ; Flamant M; Vrtovsnik F; Gauci C; Froissart M; Houillier P; Stengel B;
Am J Kidney Dis; 2011 Oct; 58(4):544-53. PubMed ID: 21803465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
